List of Studies ( Metabolite:11-HEPE)
| Study_id | Analysis_id | Study_title | Source | Species | Disease | Institute | Analysis Type |
|---|---|---|---|---|---|---|---|
| ST004133 | AN006853 | Metabolite profiling of portal and cardiac puncture plasma in C57Bl6 mice treated with Vancomycin or Metronidazole under a regular or high fat diet. | Blood | Mouse | Diabetes | Broad Institute of MIT and Harvard | LC-MS |
| ST004086 | AN006773 | Quantification of Levels of EETs and DHETs in murine plasma in Abdominal aortic constriction (AAC)-induced cardiac hypertrophy model using LC-MS | Blood | Mouse | Second Xiangya Hospital of Central South University | LC-MS | |
| ST003931 | AN006454 | Acylated putrescine therapeutic discovery for Inflammatory Bowel Diseases: HILIC-neg, C8-pos and C18-neg profiling of mouse fecal samples | Feces | Mouse | Inflammatory bowel disease | Broad Institute of MIT and Harvard | LC-MS |
| ST003876 | AN006368 | Exploration of AGMO-dependent changes in the lipid mediator profile of polarized BMDM cells (M0, M1 and M2 phenoptypes) | Macrophages | Mouse | Metabolic syndrome | University of Innsbruck | LC-MS |
| ST003534 | AN005805 | Metabolomic analysis of altered arachidonic acid metabolism in mouse heart tissue after myocardial infarction | Heart | Mouse | Cardiovascular disease | Tianjin Medical University | LC-MS |
| ST003534 | AN005805 | Metabolomic analysis of altered arachidonic acid metabolism in mouse heart tissue after myocardial infarction | Heart | Mouse | Inflammation | Tianjin Medical University | LC-MS |
| ST002354 | AN003843 | Combination of TP-252 and Naproxen elicit tumor protective Eicosanoid changes. | Blood | Rat | Cancer | UConn Health | LC-MS |
| ST002354 | AN003843 | Combination of TP-252 and Naproxen elicit tumor protective Eicosanoid changes. | Colon | Rat | Cancer | UConn Health | LC-MS |
| ST002354 | AN003845 | Combination of TP-252 and Naproxen elicit tumor protective Eicosanoid changes. | Blood | Rat | Cancer | UConn Health | LC-MS |
| ST002354 | AN003845 | Combination of TP-252 and Naproxen elicit tumor protective Eicosanoid changes. | Colon | Rat | Cancer | UConn Health | LC-MS |
| ST002246 | AN003669 | Longitudinal fecal metabolomic profiles from mothers and their infants in the EDIA study | Feces | Human | Broad Institute of MIT and Harvard | LC-MS | |
| ST001951 | AN003176 | Quantification of ω-3 fatty acids and their derivatives in lungs from hypoxia-induced pulmonary hypertension (PH) mice. | Lung | Mouse | Pulmonary hypertension | University of Tokyo | LC-MS |
| ST001215 | AN002026 | Effect of Mirabegron Treatment on serum lipidome | Blood | Human | Joslin Diabetes Center | LC-MS | |
| ST001214 | AN002025 | Lipidommics in the serum of human subjects | Blood | Human | Joslin Diabetes Center | LC-MS | |
| ST001213 | AN002024 | Serum lipidomic profile of cold-exposed Ucp1cre/12-LOX KO mice | Blood | Mouse | Joslin Diabetes Center | LC-MS | |
| ST001207 | AN002009 | Lipidomics in the serum of cold exposed mice treated with 12-LOX inhibitor LOXBlock-1 | Blood | Mouse | Joslin Diabetes Center | LC-MS | |
| ST001206 | AN002008 | Effects of cold exposure on serum lipidomic in mice | Blood | Mouse | Joslin Diabetes Center | LC-MS | |
| ST000915 | AN001485 | Biomarkers of NAFLD progression: a lipidomics approach to an epidemic. Part 2:Liver | Liver | Human | Fatty liver disease | LIPID MAPS | GC-MS/LC-MS |
